Remove contact
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – May And June

SQA

TR 43 was originally published in 2007 and revised in 2013 to address industry feedback. Although this Toolkit provides PCPC’s current thinking on MoCRA, companies should be mindful that MoCRA represents meaningful new authorities that FDA has yet to interpret and apply. TR 43 applies solely to empty glass containers.

FDA 40
article thumbnail

Monopolization in Healthcare Could Affect Access to Quality Treatment

HIT Consultant

Common industry practice today allows small groups of large, powerful pharmaceutical manufacturers to drive new drugs through regulatory processes, acting as the gatekeepers to achieve FDA approval. A study on hospital market concentration found between 2007 and 2017, one single hospital system was serving 19% of the market — 11.2

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Stephen-Johnson Syndrome (SJS) Induced by Carbamazepine

Med League

In 2007, the US Food and Drug Administration issued a post market Alert “Carbamazepine significantly increases the risk of dangerous or even fatal skin reactions [SJS and TEN] in certain patient populations…the allele is almost exclusively found in patients with ancestry across broad areas of Asia, including South Asian Indians.”

Nurses 52
article thumbnail

Stephen-Johnson Syndrome (SJS) induced by Carbamazepine – a case reviewed by Legal Nurse Consultant

Med League

In 2007, the US Food and Drug Administration issued a post market Alert “Carbamazepine significantly increases the risk of dangerous or even fatal skin reactions [SJS and TEN] in certain patient populations…the allele is almost exclusively found in patients with ancestry across broad areas of Asia, including South Asian Indians.”.

Nurses 52